|
2025
|
G/S
|
Pharmaceutical preparations for the treatment of Prader-Willi syndrome (PWS) and related disorder... |
|
2024
|
G/S
|
Promoting awareness of patient support offerings for neurodegenerative diseases and disorders and... |
|
|
Invention
|
M4 positive allosteric modulators. M4 positive allosteric modulators are disclosed which having a... |
|
|
Invention
|
M4 positive allosteric modulators. M4 positive allosterie modulators of compound of the formula w... |
|
|
G/S
|
Printed publications, namely, pamphlets, handbooks, newsletters and brochures about neurologic, g... |
|
|
G/S
|
Promoting awareness of patient support offerings for neurologic, genetic, psychologic, and psychi... |
|
|
G/S
|
Pharmaceuticals for use in the prevention and treatment of neurologic, genetic, psychologic, and ... |
|
|
Invention
|
Compounds, salts thereof and methods for treatment of diseases.
The present disclosure relates t... |
|
|
Invention
|
3-(4-cyclo-propoxybenzyl)-1-(2,4-difluorobenzyl)-1 -(1-methylpiperidin-4-yl)urea for use in the t... |
|
|
G/S
|
Printed publications in the nature of brochures, pamphlets,
newsletters, written articles and gu... |
|
|
G/S
|
Printed publications in the nature of brochures, pamphlets, newsletters, written articles and gui... |
|
|
G/S
|
Pharmaceuticals for use in the prevention and treatment of
neurologic, metabolic, genetic, psych... |
|
|
G/S
|
Pharmaceuticals preparations for use in the prevention and
treatment of neurologic, metabolic, g... |
|
2023
|
Invention
|
Carbetocin drug product and process for preparing same.
The present disclosure includes a method... |
|
|
Invention
|
Crystalline forms of trofinetide.
This disclosure provides crystalline forms of trofinetide and ... |
|
|
G/S
|
Pharmaceutical products and preparations for the treatment of Prader-Willi syndrome (PWS) and rel... |
|
|
Invention
|
Modulators of g protein-coupled receptor 88. Cycloalkylmethoxy- and cycloalkyloxy-substituted N-b... |
|
|
Invention
|
Modulators of g protein-coupled receptor 88. Alkoxy-substituted N-benzyl-2-phenylacetamide compou... |
|
|
Invention
|
Modulators of g protein-coupled receptor 88 |
|
|
Invention
|
Stable intranasal formulations of carbetocin.
The application describes stable aqueous compositi... |
|
|
Invention
|
Neuro-attenuating ketamine and norketamine compounds, derivatives thereof, and methods.
The pres... |
|
2022
|
G/S
|
Pharmaceuticals for use in the prevention and treatment of
neurologic, genetic, psychologic, and... |
|
|
Invention
|
Neuro-attenuating ketamine and norketamine compounds, derivatives thereof, and methods. The prese... |
|
|
Invention
|
Crystalline forms of trofinetide. This disclosure provides crystalline forms of trofinetide and t... |
|
|
Invention
|
Methods of treating, ameliorating, and/or preventing osteoarthritic pain. Methods of treating, am... |
|
|
Invention
|
Compounds, salts thereof and methods for treatment of diseases. The present disclosure relates to... |
|
|
Invention
|
Formulations of pimavanserin. Provided herein are capsules containing pimavanserin, processes for... |
|
|
Invention
|
Agitation process for preparing a carbetocin drug product. The present disclosure includes a meth... |
|
|
Invention
|
Methods and compositions for treatment of rett syndrome.
Disclosed herein are methods of treatin... |
|
2021
|
Invention
|
Modulators of g protein-coupled receptor 88.
Disclosed are compounds of the formula (I) and phar... |
|
|
Invention
|
Carbetocin drug product and process for preparing same. The present disclosure includes a method ... |
|
|
Invention
|
Methods of treating pain with a thiazoline anti-hyperalgesic.
Methods of treating diabetic neuro... |
|
|
Invention
|
Compounds for treating psychosis or depression. This disclosure provides, in part, a method of tr... |
|
|
Invention
|
Manufacturing methods and polymorphs of a thiazoline anti-hyperalgesic agent.
Provided herein ar... |
|
|
Invention
|
Compounds for pain treatment, compositions comprising same, and methods of using same.
The inven... |
|
|
G/S
|
Downloadable electronic publications in the nature of brochures, pamphlets, newsletters, articles... |
|
|
Invention
|
Methods for preparing n-(4-fluorobenzyl)-n-(1-methylpiperidin-4-yl)-n′-(4-(2-methylpropyloxy)phen... |
|
|
Invention
|
5-ht2a serotonin receptor inverse agonists or antagonists for use in reducing amyloid-beta peptid... |
|
|
Invention
|
Selective serotonin 2a/2c receptor inverse agonists as therapeutics for neurodegenerative disease... |
|
|
G/S
|
Pharmaceuticals for use in the prevention and treatment of neurologic, metabolic, genetic, psycho... |
|
2020
|
Invention
|
Methods for treating dementia related psychosis.
This disclosure provides, in part, a method of ... |
|
|
Invention
|
Methods and compositions for treatment of rett syndrome. Disclosed herein are methods of treating... |
|
|
Invention
|
Formulations of pimavanserin.
Provided herein are capsules containing pimavanserin, processes fo... |
|
|
G/S
|
Downloadable electronic publications in the nature of brochures, pamphlets, reports, newsletters,... |
|
|
Invention
|
Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity.
Chemical syn... |
|
|
Invention
|
Pimavanserin for treating neurodegenerative diseases.
The disclosure provides, in part, a method... |
|
|
Invention
|
Pimavanserin for treating neurodegenerative diseases. The disclosure provides, in part, a method ... |
|
|
Invention
|
Methods of treating prader-willi syndrome with carbetocin. The application describes stable aqueo... |
|
|
Invention
|
Pimavanserin for treating schizophrenia or for treating psychosis secondary to neurodegenerative ... |
|
|
Invention
|
Pimavanserin for trating schizophrenia or for treating psychosis secondary to neurodegenerative d... |
|
|
G/S
|
Scientific and industrial biotechnological and biomedical research; chemical, biochemical and mol... |
|
|
G/S
|
Providing on-line non-downloadable software for administering medical benefit and enrolling in be... |
|
|
Invention
|
Single-layer oral dose of neuro-attenuating ketamine. The present invention is directed to oral n... |
|
|
Invention
|
Manufacturing methods and polymorphs of a thiazoline anti-hyperalgesic agent. Provided herein are... |
|
2019
|
Invention
|
Methods of treating depression, anxiety and sexual dysfunction using the compound pimavanserin.
... |
|
2017
|
Invention
|
Pimavanserin alone or in combination for use in the treatment of alzheimer's disease psychosis. M... |
